Galapagos has signed a deal to jettison its troubled JAK inhibitor drug Jyseleca, agreeing to sell the rights to rheumatoid arthritis and ulcerative colitis therapy to Italy’s Alfasigma SpA in a deal ...
OSLO, Norway — A 33-year-old Czech woman managed to spend several months posing as a 13-year-old boy named "Adam," fooling teachers and child care workers in Norway, police said Thursday. Barbora ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results